This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
There is concern that corticosteroids, particularly dexamethasone administered to preterm infants starting in the first 4 days of life, cause long-term neurodevelopmental sequelae.1–3 The typical relative risk for cerebral palsy is 2.32 with a 95% confidence interval (CI) of 1.48 to 3.65 and a risk difference of 0.12 (95% CI: 0.06–0.18), which translates into a number needed to treat (or harm) of 8.3 (95% CI: 5.5–16.7).3 Barrington has noted that because of cross-over treatment of control infants the adverse effects of postnatal steroids are likely to be even greater.4 He reported a relative risk of 2.86 (95% CI: 1.95–4.19) for cerebral palsy using studies with <30% cross-over.4
Recently the Committee on Fetus and Newborn of the American Academy of Pediatrics and the Fetus and Newborn Committee of the Canadian Paediatric Society reviewed the evidence …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
